According to a new market research report "Bioburden Testing Market by Product [Instrument (PCR, Microscopes), & Consumables (Kit, Reagent)], Test (Aerobic, Anaerobic, Fungi, Spore), Application (Raw Material, In-process) & End User (Pharmaceutical, Biotechnology, CMO) - Forecast to 2019", published by MarketsandMarkets.
Browse 96 market data Tables and 46 Figures spread through 180 Pages and in-depth TOC on "Bioburden Testing Market ".
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=17983056
Bioburden testing is performed on pharmaceutical products, biotechnological products, and medical devices for quality purposes. The main aim of bioburden testing is to measure the number of viable microorganisms on the product with the help of consumables and instruments. Bioburden testing is a growing market, driven by the growing medical device industry, changing trends in the pharmaceutical and biotechnology industries, increasing food safety concerns to boost the microbial identification market, strong trend of R&D investments in life sciences, increasing product recalls due to microbial contamination, and growing awareness of bioburden testing in developing nations. However, factors such as high cost of instruments and complex and time-consuming regulatory standards to lengthen the approval process in some countries may hinder the growth of this market.
The bioburden testing market is expected to reach $565.6 Million by 2019 from $354.4 Million in 2014, growing at a CAGR of 9.8% from 2014 to 2019. This market is segmented on the basis of products, test types, applications, end users, and regions.
On the basis of products, the microbial limit testing market is segmented into consumables and instruments. The consumables market is further segmented into culture media and reagents & kits and other consumables. The instruments market is further segmented into PCR, microscopes, automated microbial identification systems, and other instruments. On the basis of test types, the global bioburden market is segmented into aerobic count, anaerobic count, fungi/mold count, and spores count. On the basis of applications, the market is segmented into raw material testing, medical devices testing, in-process testing, sterilization validation testing, and equipment cleaning validation. Based on end users, the market is segmented into pharmaceutical and biotechnology companies, medical devices manufacturers, contract manufacturing organizations (CMOs), manufacturers of food & beverage and agricultural products, and microbial testing laboratories.
For more information, visit: https://www.prnewswire.com/news-releases/bioburden-testing-market-worth-5656-million-by-2019-503774881.html